These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7255110)

  • 21. [Three cases of leukemia following cytopenia, possibly a preleukemic stage, of a long duration, with special reference to the characteristics of their autopsy findings (author's transl)].
    Okita H; Nakatsui T; Iuchi H; Fujimura K; Kamada N
    Rinsho Ketsueki; 1975 Mar; 16(3):340-6. PubMed ID: 1172046
    [No Abstract]   [Full Text] [Related]  

  • 22. Radiation-related leukemia in Hiroshima and Nagasaki, 1946-1964. I. Distribution, incidence and appearance time.
    Bizzozero OJ; Johnson KG; Ciocco A
    N Engl J Med; 1966 May; 274(20):1095-101. PubMed ID: 5932020
    [No Abstract]   [Full Text] [Related]  

  • 23. Hiroshima, Nagasaki and the RERF.
    Morgan C
    Am J Pathol; 1980 Mar; 98(3):843-56. PubMed ID: 6987891
    [No Abstract]   [Full Text] [Related]  

  • 24. Cancer risks and biomarker studies in the atomic bomb survivors.
    Preston D
    Stem Cells; 1995 May; 13 Suppl 1():40-8. PubMed ID: 7488967
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cancer incidence in atomic bomb survivors. Part III. Leukemia, lymphoma and multiple myeloma, 1950-1987.
    Preston DL; Kusumi S; Tomonaga M; Izumi S; Ron E; Kuramoto A; Kamada N; Dohy H; Matsuo T; Matsui T [corrected to Matsuo T]
    Radiat Res; 1994 Feb; 137(2 Suppl):S68-97. PubMed ID: 8127953
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dose-response relationship of neutrons and gamma rays to leukemia incidence among atomic bomb survivors in Hiroshima and Nagasaki by type of leukemia, 1950--1971.
    Ishimaru T; Otake M; Ischimaru M
    Radiat Res; 1979 Feb; 77(2):377-94. PubMed ID: 286375
    [No Abstract]   [Full Text] [Related]  

  • 27. [Method of risk estimates for genetic, leukemogenic and carcinogenic effects from medical and occupational exposures (author's transl)].
    Hashizume T; Maruyama T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1980 Dec; 40(12):1175-82. PubMed ID: 7290919
    [No Abstract]   [Full Text] [Related]  

  • 28. [The disturbances of hematopoietic organ due to atomic bomb irradiation (author's transl)].
    Ichimaru M
    Rinsho Ketsueki; 1973 Dec; 14(0):1255-63. PubMed ID: 4807685
    [No Abstract]   [Full Text] [Related]  

  • 29. [A survey on radiation-induced cancer following radiotherapy in Japan (author's transl)].
    Sakai K; Hinata H; Kitamura T; Shiina M; Inakoshi H; Saito A; Odano I; Takahashi M
    Nihon Igaku Hoshasen Gakkai Zasshi; 1981 Jan; 41(1):24-32. PubMed ID: 7232108
    [No Abstract]   [Full Text] [Related]  

  • 30. [Long-term oncological consequences of nuclear explosions].
    Trapeznikov NN
    Vestn Akad Med Nauk SSSR; 1983; (4):30-5. PubMed ID: 6868790
    [No Abstract]   [Full Text] [Related]  

  • 31. [Estimation of stochastic risk from computed tomographic examinations in Japan, 1979. 3. Estimation of population doses and stochastic risks (author's transl)].
    Nishizawa K; Maruyama T; Iwata T; Furuya Y; Hashizume T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1981 May; 41(5):436-41. PubMed ID: 7301533
    [No Abstract]   [Full Text] [Related]  

  • 32. [Preleukemic state in atomic bomb survivors, with special reference to retro- and pro-spective analysis].
    Kamada N; Uchino H
    Rinsho Ketsueki; 1972 Jun; 13(3):313-22. PubMed ID: 4674959
    [No Abstract]   [Full Text] [Related]  

  • 33. [Stochastic risk estimation from medical x-ray diagnostic examinations. 3. Population doses and population risks from x-ray diagnosis (author's transl)].
    Hashizume T; Maruyama T; Noda Y; Iwai K; Nishizawa K; Fukuhisa K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1981 Feb; 41(2):132-43. PubMed ID: 7267297
    [No Abstract]   [Full Text] [Related]  

  • 34. [Stochastic risk estimation from medical x-ray diagnostic examinations (author's transl)].
    Hashizume T; Maruyama T; Noda Y; Fukuhisa K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1980 Sep; 40(9):885-97. PubMed ID: 7454536
    [No Abstract]   [Full Text] [Related]  

  • 35. [Population doses from beam-therapy in Japan, 1978. Part 3. Estimation of malignancy significant dose and fatal malignant risk (author's transl)].
    Hashizume T; Matsuzawa H; Maruyama T; Kawachi K; Noda Y; Shiragai A; Tateno Y
    Nihon Igaku Hoshasen Gakkai Zasshi; 1981 Feb; 41(2):158-67. PubMed ID: 7267299
    [No Abstract]   [Full Text] [Related]  

  • 36. Dose response of radiation induced cancer.
    Kato H
    J UOEH; 1983 Mar; 5 Suppl():169-73. PubMed ID: 6679667
    [No Abstract]   [Full Text] [Related]  

  • 37. Leukemia and irradiation.
    Montana GS; McMillan C
    N C Med J; 1973 Oct; 34(10):785-8. PubMed ID: 4518291
    [No Abstract]   [Full Text] [Related]  

  • 38. [Risk of cancer after intake of uranium].
    Jensen PH; Søgaard-Hansen J; Ulbak K
    Ugeskr Laeger; 2001 Mar; 163(10):1411-7. PubMed ID: 11257748
    [No Abstract]   [Full Text] [Related]  

  • 39. Comments on "Leukemia risk from neutrons".
    Beebe GW; Land CE
    Health Phys; 1979 Mar; 36(3):465-6. PubMed ID: 489307
    [No Abstract]   [Full Text] [Related]  

  • 40. [Estimation of stochastic risk from computed tomography examinations in Japan, 1979. 1. The number of examinations and scans (author's transl)].
    Nishizawa K; Iwata T; Furuya Y; Maruyama T; Hashizume T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1981 Jan; 41(1):45-9. PubMed ID: 7232110
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.